Linda A Jahn1, Lee Hartline1, Nagashree Rao1, Brent Logan1, Justin J Kim1, Kevin Aylor1, Li-Ming Gan1, Helena U Westergren1, Eugene J Barrett1. 1. Departments of Medicine (L.A.J., L.H., N.R., B.L., J.J.K., K.A., E.J.B.) and Pharmacology (E.J.B.), University of Virginia School of Medicine, Charlottesville, Virginia 22908; Department of Molecular and Clinical Medicine (L.-M.G., H.U.W.), Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, SE-413 45 Gothenburg, Sweden; and CVMD iMED (L.-M.G.), Department of Research and Development, AstraZeneca, 431 83 Mölndal, Sweden.
Abstract
CONTEXT: Insulin reportedly impairs endothelial function in conduit arteries but improves it in resistance and microvascular arterioles in healthy humans. No studies have assessed endothelial function at three arterial levels in healthy or metabolic syndrome (METSYN) subjects. OBJECTIVE: The objective of the study was to compare endothelial responsiveness of conduit arteries, resistance, and microvascular arterioles to insulin in healthy and METSYN subjects. DESIGN: We assessed conduit, resistance, and microvascular arterial function in the postabsorptive and postprandial states and during euglycemic hyperinsulinemia (insulin clamp). SETTING: The study was conducted at a clinical research unit. PARTICIPANTS: Age-matched healthy and METSYN subjects participated in the study. INTERVENTIONS: We used brachial flow-mediated dilation, forearm postischemic flow velocity, and contrast-enhanced ultrasound to assess the conduit artery, resistance arteriole, and microvascular arteriolar endothelial function, respectively. We also assessed the conduit artery stiffness (pulse wave velocity and augmentation index) and measured the plasma concentrations of 92 cardiovascular disease biomarkers at baseline and after the clamp. RESULTS: Postabsorptive and postprandial endothelial function was similar in controls and METSYN in all tested vessels. METSYN subjects were metabolically insulin resistant (P < .005). In controls, but not METSYN subjects, during euglycemic hyperinsulinemia, endothelial function improved at each level of arterial vasculature (P < .05 or less for each). Conduit vessel stiffness (pulse wave velocity) was increased in the METSYN group. Twelve of 92 biomarkers differed at baseline (P < .001) and remained different at the end of the insulin clamp. CONCLUSIONS: We conclude that insulin enhances arterial endothelial function in health but not in METSYN, and this vascular insulin resistance may underlie its increased cardiovascular disease risk.
CONTEXT: Insulin reportedly impairs endothelial function in conduit arteries but improves it in resistance and microvascular arterioles in healthy humans. No studies have assessed endothelial function at three arterial levels in healthy or metabolic syndrome (METSYN) subjects. OBJECTIVE: The objective of the study was to compare endothelial responsiveness of conduit arteries, resistance, and microvascular arterioles to insulin in healthy and METSYN subjects. DESIGN: We assessed conduit, resistance, and microvascular arterial function in the postabsorptive and postprandial states and during euglycemic hyperinsulinemia (insulin clamp). SETTING: The study was conducted at a clinical research unit. PARTICIPANTS: Age-matched healthy and METSYN subjects participated in the study. INTERVENTIONS: We used brachial flow-mediated dilation, forearm postischemic flow velocity, and contrast-enhanced ultrasound to assess the conduit artery, resistance arteriole, and microvascular arteriolar endothelial function, respectively. We also assessed the conduit artery stiffness (pulse wave velocity and augmentation index) and measured the plasma concentrations of 92 cardiovascular disease biomarkers at baseline and after the clamp. RESULTS: Postabsorptive and postprandial endothelial function was similar in controls and METSYN in all tested vessels. METSYN subjects were metabolically insulin resistant (P < .005). In controls, but not METSYN subjects, during euglycemic hyperinsulinemia, endothelial function improved at each level of arterial vasculature (P < .05 or less for each). Conduit vessel stiffness (pulse wave velocity) was increased in the METSYN group. Twelve of 92 biomarkers differed at baseline (P < .001) and remained different at the end of the insulin clamp. CONCLUSIONS: We conclude that insulin enhances arterial endothelial function in health but not in METSYN, and this vascular insulin resistance may underlie its increased cardiovascular disease risk.
Authors: Mary C Corretti; Todd J Anderson; Emelia J Benjamin; David Celermajer; Francois Charbonneau; Mark A Creager; John Deanfield; Helmut Drexler; Marie Gerhard-Herman; David Herrington; Patrick Vallance; Joseph Vita; Robert Vogel Journal: J Am Coll Cardiol Date: 2002-01-16 Impact factor: 24.094
Authors: Antonio Ceriello; Claudio Taboga; Laura Tonutti; Lisa Quagliaro; Ludovica Piconi; Bruno Bais; Roberto Da Ros; Enrico Motz Journal: Circulation Date: 2002-09-03 Impact factor: 29.690
Authors: Umberto Campia; Gail Sullivan; Melissa B Bryant; Myron A Waclawiw; Michael J Quon; Julio A Panza Journal: Am J Physiol Heart Circ Physiol Date: 2003-08-28 Impact factor: 4.733
Authors: Noyan Gokce; John F Keaney; Liza M Hunter; Michael T Watkins; Zoran S Nedeljkovic; James O Menzoian; Joseph A Vita Journal: J Am Coll Cardiol Date: 2003-05-21 Impact factor: 24.094
Authors: Christian Rask-Madsen; Helena Domínguez; Nikolaj Ihlemann; Thomas Hermann; Lars Køber; Christian Torp-Pedersen Journal: Circulation Date: 2003-10-06 Impact factor: 29.690
Authors: William B Horton; Linda A Jahn; Lee M Hartline; Kevin W Aylor; James T Patrie; Eugene J Barrett Journal: J Physiol Date: 2021-02-02 Impact factor: 5.182
Authors: Brielle L Dotson; Emily M Heiston; Stephanie L Miller; Steven K Malin Journal: Am J Physiol Heart Circ Physiol Date: 2021-04-16 Impact factor: 5.125
Authors: Sara Rodrigues; Felipe X Cepeda; Edgar Toschi-Dias; Akothirene C B Dutra-Marques; Jefferson C Carvalho; Valéria Costa-Hong; Maria Janieire N N Alves; Maria Urbana P B Rondon; Luiz A Bortolotto; Ivani C Trombetta Journal: J Clin Hypertens (Greenwich) Date: 2017-09-04 Impact factor: 3.738